ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 65 filers reported holding ACORDA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 14.66 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $12,000 | -61.3% | 16,858 | -71.6% | 0.00% | – |
| Q3 2020 | $31,000 | -39.2% | 59,268 | -15.3% | 0.00% | – |
| Q2 2020 | $51,000 | -13.6% | 70,003 | +11.0% | 0.00% | – |
| Q1 2020 | $59,000 | -51.6% | 63,040 | +5.7% | 0.00% | – |
| Q4 2019 | $122,000 | +34.1% | 59,617 | +88.1% | 0.00% | – |
| Q3 2019 | $91,000 | -45.8% | 31,699 | +45.5% | 0.00% | – |
| Q2 2019 | $168,000 | -81.1% | 21,782 | -67.4% | 0.00% | – |
| Q1 2019 | $887,000 | -63.8% | 66,735 | -57.6% | 0.00% | -100.0% |
| Q4 2018 | $2,451,000 | +329.2% | 157,305 | +441.4% | 0.00% | – |
| Q3 2018 | $571,000 | +302.1% | 29,053 | +485.9% | 0.00% | – |
| Q2 2018 | $142,000 | -94.3% | 4,959 | -95.3% | 0.00% | -100.0% |
| Q1 2018 | $2,501,000 | +38.2% | 105,749 | +25.4% | 0.00% | 0.0% |
| Q4 2017 | $1,810,000 | -5.1% | 84,355 | +4.6% | 0.00% | 0.0% |
| Q3 2017 | $1,907,000 | +157.0% | 80,656 | +114.1% | 0.00% | – |
| Q2 2017 | $742,000 | +144.9% | 37,669 | +161.1% | 0.00% | – |
| Q1 2017 | $303,000 | -63.0% | 14,425 | -66.8% | 0.00% | – |
| Q4 2016 | $818,000 | +88.0% | 43,492 | +108.8% | 0.00% | – |
| Q3 2016 | $435,000 | -70.4% | 20,829 | -63.9% | 0.00% | -100.0% |
| Q2 2016 | $1,470,000 | -1.5% | 57,655 | +2.2% | 0.00% | 0.0% |
| Q1 2016 | $1,492,000 | -16.1% | 56,407 | +35.7% | 0.00% | 0.0% |
| Q4 2015 | $1,778,000 | -15.4% | 41,566 | -47.5% | 0.00% | 0.0% |
| Q3 2015 | $2,101,000 | -33.9% | 79,245 | -16.9% | 0.00% | -50.0% |
| Q2 2015 | $3,180,000 | -7.0% | 95,403 | -7.2% | 0.00% | 0.0% |
| Q1 2015 | $3,421,000 | -55.7% | 102,782 | -45.6% | 0.00% | -60.0% |
| Q4 2014 | $7,715,000 | – | 188,790 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |